Related Experiment Videos

[Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis]

|January 1, 1980

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis.

Leukemia·2016

Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management.

Hematology (Amsterdam, Netherlands)·2016

A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis.

Blood cancer journal·2015

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

The New England journal of medicine·2013

Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.

Leukemia·2012

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.

Leukemia·2012

See all related articles